Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.622
-0.078 (-4.59%)
At close: Mar 2, 2026
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 463.6 million as of March 2, 2026. Its market cap has increased by 43.63% in one year.
Market Cap
463.60M
Enterprise Value
530.57M
Revenue
71.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.62
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 463.60M, a decrease of -72.23%. That is a compound annual growth rate of -13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 463.60M | -64.62% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 864.03M |
| Infant Bacterial Therapeutics AB | 677.61M |
| FluoGuide | 585.31M |
| Corline Biomedical AB | 405.97M |
| Ascelia Pharma AB | 397.73M |
| Lipum AB | 307.58M |
| Elicera Therapeutics AB | 299.46M |
| Bio-Works Technologies AB | 291.31M |